Currently, there are 282.25M common shares owned by the public and among those 209.31M shares have been available to trade.
The company’s stock has a 5-day price change of 52.08% and 46.73% over the past three months. PL shares are trading 44.55% year to date (YTD), with the 12-month market performance up to 228.09% higher. It has a 12-month low price of $1.73 and touched a high of $6.71 over the same period. PL has an average intraday trading volume of 5.02 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 44.70%, 61.35%, and 62.96% respectively.
Institutional ownership of Planet Labs PBC (NYSE: PL) shares accounts for 33.85% of the company’s 282.25M shares outstanding.
It has a market capitalization of $1.77B and a beta (3y monthly) value of 1.59. The earnings-per-share (ttm) stands at -$0.36. Price movements for the stock have been influenced by the stock’s volatility, which stands at 19.69% over the week and 9.30% over the month.
Analysts forecast that Planet Labs PBC (PL) will achieve an EPS of -0.05 for the current quarter, -0.05 for the next quarter and -0.11 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.06 while analysts give the company a high EPS estimate of -0.06. Comparatively, EPS for the current quarter was -0.06 a year ago. Earnings per share for the fiscal year are expected to increase by 32.83%, and 5.79% over the next financial year. EPS should grow at an annualized rate of 32.92% over the next five years, compared to 31.85% over the past 5-year period.
Looking at the support for the PL, a number of firms have released research notes about the stock. Goldman stated their Neutral rating for the stock in a research note on April 11, 2025, with the firm’s price target at $3.50. Craig Hallum coverage for the Planet Labs PBC (PL) stock in a research note released on January 30, 2025 offered a Buy rating with a price target of $7. Cantor Fitzgerald was of a view on January 24, 2025 that the stock is Overweight, while Needham gave the stock Buy rating on September 06, 2024, issuing a price target of $7- $5. Craig Hallum on their part issued Hold rating on December 08, 2023.
